- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Intraocular Melanoma
Total 3570 results
-
Dr. Ronnie ShapiraNot yet recruitingMetastatic Melanoma | Malignant Melanoma | Immunotherapy | Malignant Melanoma Stage IV | BRAF V600E
-
Elizabeth DavisBristol-Myers SquibbTerminatedMetastatic Melanoma | Advanced Melanoma | Metastatic Melanoma Stratified by MHC-II ExpressionUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV MelanomaUnited States
-
Assistance Publique - Hôpitaux de ParisUnknownStage IV Melanoma | Stage III Melanoma | Amplification | Malignant Skin Melanoma T0France
-
NewLink Genetics CorporationTerminatedMetastatic Melanoma | Stage IV MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant Melanoma, CancerHungary
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsUnited States, South Africa, Croatia, Brazil, Egypt
-
Lynn E. Spitler, MDGenentech, Inc.; Celgene CorporationCompletedMetastatic Malignant MelanomaUnited States
-
Perspective TherapeuticsRecruitingMetastatic Melanoma | Melanoma (Skin) | Mucosal Melanoma | Melanoma Stage IV | Melanoma Stage III | Melanoma, UvealUnited States
-
Delcath Systems Inc.IQVIA BiotechCompletedMelanoma, OcularUnited States, Spain, Italy, Germany, United Kingdom, Switzerland, Belgium, Austria, France
-
Jonsson Comprehensive Cancer CenterCompleted
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); National Comprehensive Cancer NetworkTerminatedRecurrent Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Stage IIB Melanoma (Locally Advanced) | Stage IIC Melanoma (Locally Advanced) | Stage IV Melanoma (Limited, Resectable)United States
-
Centre Hospitalier Universitaire de NiceUnknownMalignant Melanoma Stage III | Malignant Melanoma Stage IV
-
Regina Elena Cancer InstituteRecruitingMelanoma (Skin) | Liquid Biopsy | Melanoma Stage IV | Melanoma Stage III | BRAF V600EItaly
-
Universitair Ziekenhuis BrusselRecruitingMelanoma Stage IV | Melanoma Stage IIIBelgium
-
Evaxion Biotech A/SMerck Sharp & Dohme LLCRecruitingMelanoma Stage IV | Melanoma Stage IIIAustralia
-
The Netherlands Cancer InstituteRecruiting
-
University of California, San FranciscoArray BioPharmaRecruitingMelanoma Stage IV | Melanoma Stage IIIUnited States
-
Pierre Fabre Pharma GmbHPierre Fabre Pharma Austria; Pierre Fabre Pharma AGRecruitingMelanoma Stage IV | Melanoma Stage IIIAustria, Germany, Switzerland
-
The Netherlands Cancer InstituteAmgenActive, not recruitingMelanoma Stage IV | Melanoma Stage IIINetherlands
-
Universitair Ziekenhuis BrusselCompletedStage IV Melanoma | Stage III MelanomaBelgium
-
Melanoma and Skin Cancer Trials LimitedBristol-Myers Squibb; Amgen; Peter MacCallum Cancer Centre, AustraliaActive, not recruitingMelanoma | Melanoma Stage Iv | Melanoma Stage IiiAustralia
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownAdvanced Acral Malignant MelanomaChina
-
National Cancer Institute (NCI)TerminatedStage IV Melanoma | Stage III MelanomaUnited States
-
IDEAYA BiosciencesRecruitingColorectal Cancer | Metastatic Uveal Melanoma | Cutaneous Melanoma | Other Solid TumorsUnited States, Australia, Canada
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Stage IIIc MelanomaUnited States
-
National Cancer Institute (NCI)CompletedSorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable MelanomaMelanoma | Recurrent Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
MelanomaPRO, RussiaNovartisRecruitingMelanoma | Melanoma Stage IV | Melanoma Stage IIIRussian Federation
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingMalignant Melanoma Stage IIIAustria, Netherlands, Australia, Sweden
-
Eisai Inc.PharmaBio Development Inc.CompletedStage IV Melanoma | Stage IIIC MelanomaUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbWithdrawnMelanoma Stage IV | Melanoma Stage IIIUnited States
-
Immutep Australia Pty. Ltd.CompletedStage IV Melanoma | Stage III MelanomaAustralia
-
National Cancer Institute (NCI)CompletedSorafenib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By SurgeryStage IV Melanoma | Stage III MelanomaUnited States
-
National Cancer Institute (NCI)TerminatedMelanoma | Malignant Melanoma | Melanoma, ExperimentalUnited States
-
Mannkind CorporationTerminatedStage IV Melanoma | Stage III MelanomaUnited States
-
Steinar AamdalTerminatedMetastatic Malignant MelanomaNorway
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalCompletedMelanoma | Acral Melanoma | Mucosal Lentiginous MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsBelgium, Spain, Germany, Netherlands, Finland
-
Eli Lilly and CompanyCompletedMetastatic Malignant MelanomaUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Mucosal MelanomaUnited States
-
National Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol Specific | Recurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
Pierre Fabre MedicamentBiotrialActive, not recruitingMelanoma | Metastatic Melanoma | Unresectable Melanoma | BRAF V600 MutationFrance
-
Syneos HealthOncolys BioPharma IncUnknownMelanoma Stage Iv | Melanoma Stage IIIUnited States
-
Sheba Medical CenterUnknownMelanoma Stage Iv | Unresectable Stage III MelanomaIsrael
-
National Cancer Institute (NCI)CompletedPrecancerous Condition | Stage II Melanoma | Stage 0 Melanoma | Stage I MelanomaUnited States
-
Pierre Fabre MedicamentRecruitingMetastatic Melanoma | Melanoma (Skin) | BRAF V600 MutationPortugal
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Pfizer; Beth Israel Deaconess Medical CenterCompletedMucosal Lentiginous Melanoma | Acral Lentiginous Malignant MelanomaUnited States
-
Mannkind CorporationCompletedAdvanced Melanoma | Stage III and IV MelanomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States